Trueblood Wealth Management’s iShares S&P Mid-Cap 400 Growth ETF IJK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Buy
3,642
+3
+0.1% +$333 0.15% 174
2026
Q1
$366K Buy
3,639
+3
+0.1% +$308 0.14% 179
2025
Q4
$352K Buy
3,636
+7
+0.2% +$674 0.14% 184
2025
Q3
$348K Buy
3,629
+5
+0.1% +$471 0.14% 191
2025
Q2
$330K Buy
3,624
+5
+0.1% +$428 0.14% 191
2025
Q1
$301K Hold
3,619
0.14% 188
2024
Q4
$329K Sell
3,619
-8
-0.2% -$753 0.16% 173
2024
Q3
$333K Hold
3,627
0.17% 165
2024
Q2
$320K Hold
3,627
0.18% 154
2024
Q1
$331K Hold
3,627
0.19% 146
2023
Q4
$287K Buy
+3,627
New +$266K 0.18% 160

Other funds holding IJK

Trueblood Wealth Management's IJK Position: Q2 2026 in Review

Trueblood Wealth Management increased its iShares S&P Mid-Cap 400 Growth ETF (IJK) stake by 0.08% in Q2 2026, buying an estimated $333 and bringing the position to 3,642 shares worth $428K. The position accounts for 0.15% of the portfolio, ranked #174.

Trueblood Wealth Management first reported a position in IJK in Q4 2023 and has held it in 11 quarters since. 990 funds tracked by Wall St. Rank hold IJK as of Q2 2026.

  • Trueblood Wealth Management held 3,642 shares of iShares S&P Mid-Cap 400 Growth ETF worth $428K as of Q2 2026.
  • Trueblood Wealth Management bought 3 iShares S&P Mid-Cap 400 Growth ETF shares in Q2 2026, an estimated $333.
  • iShares S&P Mid-Cap 400 Growth ETF made up 0.15% of Trueblood Wealth Management's portfolio in Q2 2026, its #174 holding.
  • Trueblood Wealth Management first reported a position in iShares S&P Mid-Cap 400 Growth ETF in Q4 2023 and has held it in 11 quarters since.
  • 990 funds tracked by Wall St. Rank held iShares S&P Mid-Cap 400 Growth ETF as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.